207 related articles for article (PubMed ID: 15279811)
1. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome.
O'Driscoll M; Gennery AR; Seidel J; Concannon P; Jeggo PA
DNA Repair (Amst); 2004; 3(8-9):1227-35. PubMed ID: 15279811
[TBL] [Abstract][Full Text] [Related]
2. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV.
Buck D; Moshous D; de Chasseval R; Ma Y; le Deist F; Cavazzana-Calvo M; Fischer A; Casanova JL; Lieber MR; de Villartay JP
Eur J Immunol; 2006 Jan; 36(1):224-35. PubMed ID: 16358361
[TBL] [Abstract][Full Text] [Related]
3. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.
O'Driscoll M; Ruiz-Perez VL; Woods CG; Jeggo PA; Goodship JA
Nat Genet; 2003 Apr; 33(4):497-501. PubMed ID: 12640452
[TBL] [Abstract][Full Text] [Related]
4. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.
van der Burg M; van Veelen LR; Verkaik NS; Wiegant WW; Hartwig NG; Barendregt BH; Brugmans L; Raams A; Jaspers NG; Zdzienicka MZ; van Dongen JJ; van Gent DC
J Clin Invest; 2006 Jan; 116(1):137-45. PubMed ID: 16357942
[TBL] [Abstract][Full Text] [Related]
5. Nbs1 is required for ATR-dependent phosphorylation events.
Stiff T; Reis C; Alderton GK; Woodbine L; O'Driscoll M; Jeggo PA
EMBO J; 2005 Jan; 24(1):199-208. PubMed ID: 15616588
[TBL] [Abstract][Full Text] [Related]
6. The DNA Ligase IV Syndrome R278H Mutation Impairs B Lymphopoiesis via Error-Prone Nonhomologous End-Joining.
Park J; Welner RS; Chan MY; Troppito L; Staber PB; Tenen DG; Yan CT
J Immunol; 2016 Jan; 196(1):244-55. PubMed ID: 26608917
[TBL] [Abstract][Full Text] [Related]
7. Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome.
Rucci F; Notarangelo LD; Fazeli A; Patrizi L; Hickernell T; Paganini T; Coakley KM; Detre C; Keszei M; Walter JE; Feldman L; Cheng HL; Poliani PL; Wang JH; Balter BB; Recher M; Andersson EM; Zha S; Giliani S; Terhorst C; Alt FW; Yan CT
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3024-9. PubMed ID: 20133615
[TBL] [Abstract][Full Text] [Related]
8. Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel Syndrome.
Ogi T; Walker S; Stiff T; Hobson E; Limsirichaikul S; Carpenter G; Prescott K; Suri M; Byrd PJ; Matsuse M; Mitsutake N; Nakazawa Y; Vasudevan P; Barrow M; Stewart GS; Taylor AM; O'Driscoll M; Jeggo PA
PLoS Genet; 2012; 8(11):e1002945. PubMed ID: 23144622
[TBL] [Abstract][Full Text] [Related]
9. DNA strand break repair and human genetic disease.
McKinnon PJ; Caldecott KW
Annu Rev Genomics Hum Genet; 2007; 8():37-55. PubMed ID: 17887919
[TBL] [Abstract][Full Text] [Related]
10. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling.
Griffith E; Walker S; Martin CA; Vagnarelli P; Stiff T; Vernay B; Al Sanna N; Saggar A; Hamel B; Earnshaw WC; Jeggo PA; Jackson AP; O'Driscoll M
Nat Genet; 2008 Feb; 40(2):232-6. PubMed ID: 18157127
[TBL] [Abstract][Full Text] [Related]
11. A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.
van der Burg M; Ijspeert H; Verkaik NS; Turul T; Wiegant WW; Morotomi-Yano K; Mari PO; Tezcan I; Chen DJ; Zdzienicka MZ; van Dongen JJ; van Gent DC
J Clin Invest; 2009 Jan; 119(1):91-8. PubMed ID: 19075392
[TBL] [Abstract][Full Text] [Related]
12. Ligase IV syndrome.
Chistiakov DA
Adv Exp Med Biol; 2010; 685():175-85. PubMed ID: 20687505
[TBL] [Abstract][Full Text] [Related]
13. Primary microcephaly, impaired DNA replication, and genomic instability caused by compound heterozygous ATR mutations.
Mokrani-Benhelli H; Gaillard L; Biasutto P; Le Guen T; Touzot F; Vasquez N; Komatsu J; Conseiller E; Pïcard C; Gluckman E; Francannet C; Fischer A; Durandy A; Soulier J; de Villartay JP; Cavazzana-Calvo M; Revy P
Hum Mutat; 2013 Feb; 34(2):374-84. PubMed ID: 23111928
[TBL] [Abstract][Full Text] [Related]
14. Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway.
Alderton GK; Joenje H; Varon R; Børglum AD; Jeggo PA; O'Driscoll M
Hum Mol Genet; 2004 Dec; 13(24):3127-38. PubMed ID: 15496423
[TBL] [Abstract][Full Text] [Related]
15. Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.
Zhang X; Succi J; Feng Z; Prithivirajsingh S; Story MD; Legerski RJ
Mol Cell Biol; 2004 Oct; 24(20):9207-20. PubMed ID: 15456891
[TBL] [Abstract][Full Text] [Related]
16. Ligase IV syndrome.
Chistiakov DA; Voronova NV; Chistiakov AP
Eur J Med Genet; 2009; 52(6):373-8. PubMed ID: 19467349
[TBL] [Abstract][Full Text] [Related]
17. Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development.
Sekiguchi J; Ferguson DO; Chen HT; Yang EM; Earle J; Frank K; Whitlow S; Gu Y; Xu Y; Nussenzweig A; Alt FW
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3243-8. PubMed ID: 11248063
[TBL] [Abstract][Full Text] [Related]
18. Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development.
Orii KE; Lee Y; Kondo N; McKinnon PJ
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):10017-22. PubMed ID: 16777961
[TBL] [Abstract][Full Text] [Related]
19. Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling.
O'Driscoll M; Dobyns WB; van Hagen JM; Jeggo PA
Am J Hum Genet; 2007 Jul; 81(1):77-86. PubMed ID: 17564965
[TBL] [Abstract][Full Text] [Related]
20. The clinical impact of deficiency in DNA non-homologous end-joining.
Woodbine L; Gennery AR; Jeggo PA
DNA Repair (Amst); 2014 Apr; 16():84-96. PubMed ID: 24629483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
